中商官网
研究报告
康辰药业（603590）
主要经济指标
| 类别\年份 | 营业收入 （元) |
营业利润 （元) |
利润总额 （元) |
净利润 （元) |
资产总计 （元) |
负债合计 （元) |
股东权益合计 （元) |
| 2013 | 598000000.0000 | 119000000.0000 | 136000000.0000 | 119000000.0000 | 515000000.0000 | 202000000.0000 | 313000000.0000 |
| 2014 | 544000000.0000 | 190000000.0000 | 200000000.0000 | 176000000.0000 | 665000000.0000 | 177000000.0000 | 488000000.0000 |
| 2015 | 436000000.0000 | 204000000.0000 | 222000000.0000 | 195000000.0000 | 846000000.0000 | 163000000.0000 | 683000000.0000 |
| 2016 | 346000000.0000 | 208000000.0000 | 218000000.0000 | 192000000.0000 | 1022000000.0000 | 147000000.0000 | 875000000.0000 |
| 2017 | 591000000.0000 | 557000000.0000 | 575000000.0000 | 479000000.0000 | 1674000000.0000 | 319000000.0000 | 1355000000.0000 |
| 2018 | 1022000000.0000 | 300000000.0000 | 300000000.0000 | 264000000.0000 | 2920000000.0000 | 439000000.0000 | 2481000000.0000 |
| 2019 | 1066000000.0000 | 300000000.0000 | 299000000.0000 | 266000000.0000 | 3174000000.0000 | 446000000.0000 | 2728000000.0000 |
| 2020 | 809000000.0000 | 210000000.0000 | 208000000.0000 | 183000000.0000 | 3786000000.0000 | 702000000.0000 | 3084000000.0000 |
| 2021 | 810000000.0000 | 192000000.0000 | 189000000.0000 | 167000000.0000 | 3371000000.0000 | 241000000.0000 | 3131000000.0000 |
| 2022 | 867000000.0000 | 141000000.0000 | 140000000.0000 | 124000000.0000 | 3425000000.0000 | 235000000.0000 | 3190000000.0000 |
| 2023 | 920000000.0000 | 143000000.0000 | 123000000.0000 | 188000000.0000 | 3781000000.0000 | 418000000.0000 | 3362000000.0000 |
| 2024 | 825000000.0000 | 39087800.0000 | 38863700.0000 | 21530500.0000 | 3920000000.0000 | 494000000.0000 | 3426000000.0000 |
盈利能力分析
| 类别\年份 | 销售毛利率 （%) |
营业利润率 （%) |
总资产利润率 （%) |
净资产收益率 | 存货周转率 | 应收账款周转率 （次) |
总资产周转率 （次) |
| 2013 | 18.90 | 22.74 | 26.41 | 47.1300 | 2.9000 | 39.30 | 1.16 |
| 2014 | 30.15 | 36.76 | 30.08 | 43.9800 | 2.8800 | 44.55 | 0.82 |
| 2015 | 38.07 | 50.92 | 26.24 | 33.3400 | 2.9500 | -- | 0.52 |
| 2016 | 47.11 | 63.01 | 21.33 | 24.6000 | 2.2500 | -- | 0.34 |
| 2017 | 32.49 | 97.29 | 34.35 | 42.9700 | 2.3900 | -- | 0.35 |
| 2018 | 24.76 | 29.35 | 10.27 | 14.7900 | 3.7300 | 4.67 | 0.35 |
| 2019 | 23.83 | 28.05 | 9.42 | 10.2500 | 4.8300 | 4.90 | 0.34 |
| 2020 | 19.53 | 25.71 | 5.49 | 6.5100 | 2.4600 | 4.14 | 0.21 |
| 2021 | 17.04 | 23.33 | 5.61 | 5.0200 | 2.6100 | 3.96 | 0.24 |
| 2022 | 15.34 | 16.15 | 4.09 | 3.4900 | 3.0000 | 3.39 | 0.25 |
| 2023 | 13.80 | 13.37 | 3.25 | 5.0300 | 2.3600 | 3.40 | 0.24 |
| 2024 | 2.06 | 4.71 | 0.99 | 1.3600 | 1.4300 | 3.21 | 0.21 |
偿债能力分析
| 类别\年份 | 资产负债率 （%) |
股东权益比率 （%) |
流动比率 | 速动比率 |
| 2013 | 39.22 | 60.78 | 0.8700 | 0.8000 |
| 2014 | 26.62 | 73.38 | 2.1900 | 0.4300 |
| 2015 | 19.27 | 80.73 | 3.8600 | 0.4400 |
| 2016 | 14.38 | 85.62 | 3.9900 | 2.6000 |
| 2017 | 19.06 | 80.94 | 3.2200 | 3.0800 |
| 2018 | 15.03 | 84.97 | 5.9700 | 5.9300 |
| 2019 | 14.05 | 85.95 | 6.3600 | 6.3000 |
| 2020 | 18.54 | 81.46 | 3.0400 | 2.9700 |
| 2021 | 7.15 | 92.88 | 6.1200 | 5.5500 |
| 2022 | 6.86 | 93.14 | 5.9000 | 5.5100 |
| 2023 | 11.06 | 88.92 | 3.8000 | 2.9200 |
| 2024 | 12.60 | 87.40 | 3.0800 | 2.6400 |
成本费用分析
| 类别\年份 | 营业成本 （元) |
销售费用 （元) |
管理费用 （元) |
财务费用 （元) |
| 2013 | 485000000.0000 | 383000000.0000 | 64070000.0000 | 297500.0000 |
| 2014 | 380000000.0000 | 271000000.0000 | 65764800.0000 | -365700.0000 |
| 2015 | 270000000.0000 | 134000000.0000 | 51015300.0000 | -914400.0000 |
| 2016 | 183000000.0000 | 76976300.0000 | 24078900.0000 | -845200.0000 |
| 2017 | 399000000.0000 | 291000000.0000 | 28269700.0000 | -11212800.0000 |
| 2018 | 769000000.0000 | 603000000.0000 | 45560300.0000 | -35112700.0000 |
| 2019 | 812000000.0000 | 637000000.0000 | 41847200.0000 | -62266300.0000 |
| 2020 | 651000000.0000 | 473000000.0000 | 62365300.0000 | 418600.0000 |
| 2021 | 672000000.0000 | 391000000.0000 | 88057400.0000 | 741900.0000 |
| 2022 | 734000000.0000 | 423000000.0000 | 103000000.0000 | 1612500.0000 |
| 2023 | 793000000.0000 | 473000000.0000 | 111000000.0000 | 4148300.0000 |
| 2024 | 808000000.0000 | 418000000.0000 | 135000000.0000 | 8971900.0000 |